Reveal HealthTech Partners with CancerX to Accelerate Cancer Innovation! Learn More Here.


Reveal HealthTech Partners with CancerX and the CancerX Accelerator Program to Transform Cancer Treatment


Announced by the White House Cancer Moonshot in February 2023, CancerX is a public-private partnership to boost innovation in the fight against cancer. CancerX is co-hosted by the Moffitt Cancer Center and Digital Medicine Society (DiMe), alongside the Office for the National Coordinator for Health Information Technology (ONC) and Office of the Assistant Secretary for Health (OASH).

Read more about our partnership.

CancerX Accelerator

The CancerX Accelerator program aims to promote and fortify digital innovations in oncology by providing promising startups with an opportunity to directly work with leading cancer organizations, including providers, payers, and pharmaceutical companies. These startups will receive mentorship, training, and direct connections with these enterprise partners to build, test, and implement their cancer innovations at scale.

Why Reveal is Teaming with CancerX to Advance Cancer Treatment

Reveal HealthTech was founded to help solve some of the most challenging problems in healthcare by bringing together clinical perspective and engineering excellence. And there is no bigger problem in healthcare than cancer. We are very excited about this partnership and look forward to working with the community to reduce cancer-related deaths and elevate the quality of cancer care.

Sanchit Mullick

Cancer is a devastating disease that affects millions of people around the world. By working together, we can make a real difference in the lives of cancer patients and their families.

Dr. Salim Afshar, MD, DMD, FACS
Chief Medical & Innovation Officer

The CancerX Accelerator offers an opportunity to harness the full power of innovation to achieve the goals of the Cancer Moonshot & democratize access to life-changing treatments.

Andrew Bravo
Vice President of Business Development & Strategy

Reach out to learn how we leverage technology to overcome the distinct challenges in cancer care